ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 232 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,597,006 | +40.9% | 316,555 | +61.9% | 0.13% | +38.0% |
| Q2 2023 | $4,682,153 | +115.0% | 195,497 | +69.0% | 0.09% | +109.1% |
| Q1 2023 | $2,177,455 | +94.2% | 115,699 | +45.4% | 0.04% | -12.0% |
| Q2 2022 | $1,121,000 | +124.6% | 79,579 | +272.5% | 0.05% | +78.6% |
| Q4 2021 | $499,000 | -35.4% | 21,366 | -28.7% | 0.03% | -75.2% |
| Q1 2021 | $773,000 | +257.9% | 29,975 | +643.1% | 0.11% | +222.9% |
| Q4 2020 | $216,000 | -71.4% | 4,034 | -77.9% | 0.04% | -78.5% |
| Q3 2020 | $754,000 | – | 18,287 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 556,553 | $11,598,565 | 5.78% |
| Baker Brothers Advisors | 42,864,612 | $893,298,514 | 5.15% |
| RTW INVESTMENTS, LP | 11,576,537 | $241,255,031 | 5.09% |
| Palo Alto Investors LP | 2,405,793 | $50,136,726 | 4.74% |
| Birchview Capital, LP | 240,400 | $5,009,936 | 4.26% |
| EcoR1 Capital, LLC | 5,991,479 | $124,862,422 | 4.21% |
| EMERALD ADVISERS, LLC | 1,681,052 | $35,033,124 | 1.70% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,303,988 | $27,175,110 | 1.64% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 179,702 | $3,739,599 | 1.26% |
| SECTOR GAMMA AS | 179,785 | $3,746,719 | 0.96% |